Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Bipolar Disorder Drugs and Treatment Market

Bipolar Disorder Drugs and Treatment Market Size

  • Report ID: GMI5795
  • Published Date: May 2023
  • Report Format: PDF

Bipolar Disorder Drugs and Treatment Market Size

Bipolar Disorder Drugs and Treatment Market size was valued at around USD 5.2 billion in 2022 and is expected to register over 3.5% CAGR between 2023 and 2032. Government efforts to raise awareness of bipolar diseases will significantly raise the demand for bipolar disorder drugs and treatment, and this trend is anticipated to continue over the projection period.

 

Over the past few years, there has been an increase in focus on mental health, largely due to rising levels of stress among the global population. This could potentially increase the product demand. Other variables that will affect market growth include increasing product approvals, speedy progress in treatment development, and an increase in the number of bipolar disorder cases.

 

Bipolar disorder is a mental health condition that affects an individual’s ability to regulate mood and emotions, which can result in episodes of extreme highs (mania or hypomania) and lows (depression). Bipolar disorder drugs and treatment refer to the medications and therapies used to manage symptoms of bipolar disorder. The primary role of bipolar disorder drugs and treatment is to stabilize mood, reduce the severity and frequency of mood swings, and improve overall quality of life for individuals with the condition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bipolar disorder drugs and treatment industry size was USD 5.2 billion in 2022 and will reach USD 7.5 billion by 2032 due to the surging government efforts for raising awareness of bipolar diseases.

Bipolar disorder drugs and treatment industry share from the anti-psychotic drugs segment recorded USD 2.1 billion in 2022 owing to the growing need to control psychotic symptoms such as delusions, hallucinations, and mania in bipolar disorder.

The oral route of administration held 59.2% of the bipolar disorder drugs and treatment industry share in 2022 due to their easy consumption.

U.S. bipolar disorder drugs and treatment industry size reached USD 1.9 billion in 2022 due to the increasing prevalence of bipolar disorders in the region.

Bipolar Disorder Drugs and Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 352
  • Countries covered: 32
  • Pages: 210
 Download Free Sample